日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study

布地加利单抗(一种抗PD-1抑制剂)治疗HIV-1感染者的随机、安慰剂对照1b期研究

Moti N Ramgopal ,Jacob P Lalezari ,Ana Gabriela Pires Dos Santos ,Preethi Krishnan ,Tanaya R Vaidya ,Fei Zhou ,Heide Betman ,Patrick Dorr ,Nael M Mostafa ,Maria L Alcaide ,Franco Felizarta ,Jean-Pierre Routy

A discovery-based proteomics approach identifies protein disulphide isomerase (PDIA1) as a biomarker of β cell stress in type 1 diabetes

基于发现的蛋白质组学方法将蛋白质二硫键异构酶 (PDIA1) 鉴定为 1 型糖尿病中 β 细胞应激的生物标志物

Farooq Syed, Divya Singhal, Koen Raedschelders, Preethi Krishnan, Robert N Bone, Madeline R McLaughlin, Jennifer E Van Eyk, Raghavendra G Mirmira, Mei-Ling Yang, Mark J Mamula, Huanmei Wu, Xiaowen Liu, Carmella Evans-Molina

SERCA2 regulates proinsulin processing and processing enzyme maturation in pancreatic beta cells

SERCA2 调节胰腺 β 细胞中的胰岛素原加工和加工酶成熟

Hitoshi Iida #, Tatsuyoshi Kono #, Chih-Chun Lee, Preethi Krishnan, Matthew C Arvin, Staci A Weaver, Timothy S Jarvela, Renato C S Branco, Madeline R McLaughlin, Robert N Bone, Xin Tong, Peter Arvan, Iris Lindberg, Carmella Evans-Molina

β Cell microRNAs Function as Molecular Hubs of Type 1 Diabetes Pathogenesis and as Biomarkers of Diabetes Risk

β 细胞 microRNA 是 1 型糖尿病发病机制的分子枢纽,也是糖尿病风险的生物标志物

Farooq Syed, Preethi Krishnan, Garrick Chang, Sarah R Langlais, Sumon Hati, Kentaro Yamada, Anh K Lam, Sayali Talware, Xiaowen Liu, Rajesh Sardar, Jing Liu, Raghavendra G Mirmira, Carmella Evans-Molina0

Evaluation of deoxypyridinoline levels in gingival crevicular fluid and serum as alveolar bone loss biomarker in patients with periodontitis

评估龈沟液和血清中脱氧吡啶林水平作为牙周炎患者牙槽骨吸收生物标志物

Suhail Syed, Vinathi Reddy Kankara, Krishnanjeya Reddy Pathakota, Preethi Krishnan, Ashank Mishra

Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan

日本接受格卡瑞韦和哌仑他韦治疗的丙型肝炎病毒感染患者的 CERTAIN-1 和 CERTAIN-2 研究综合耐药性分析

Preethi Krishnan, Gretja Schnell, Rakesh Tripathi, Jill Beyer, Thomas Reisch, Tatyana Dekhtyar, Michelle Irvin, Wangang Xie, Bo Fu, Margaret Burroughs, Rebecca Redman, Hiromitsu Kumada, Kazuaki Chayama, Christine Collins, Tami Pilot-Matias

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

慢性丙型肝炎病毒基因型 1 感染患者使用格卡瑞韦或哌仑他韦进行 3 天单药治疗研究的耐药性分析

Teresa I Ng, Tami Pilot-Matias, Rakesh Tripathi, Gretja Schnell, Preethi Krishnan, Thomas Reisch, Jill Beyer, Tatyana Dekhtyar, Michelle Irvin, Liangjun Lu, Armen Asatryan, Andrew Campbell, Betty Yao, Sandra Lovell, Federico Mensa, Eric J Lawitz, Jens Kort, Christine Collins

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

下一代丙型肝炎病毒 NS3/4A 蛋白酶抑制剂 Glecaprevir 的体外抗病毒活性和耐药性特征

Teresa I Ng, Rakesh Tripathi, Thomas Reisch, Liangjun Lu, Timothy Middleton, Todd A Hopkins, Ron Pithawalla, Michelle Irvin, Tatyana Dekhtyar, Preethi Krishnan, Gretja Schnell, Jill Beyer, Keith F McDaniel, Jun Ma, Guoqiang Wang, Li-Juan Jiang, Yat Sun Or, Dale Kempf, Tami Pilot-Matias, Christine Co

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

下一代丙型肝炎病毒 NS5A 抑制剂 Pibrentasvir 的体外抗病毒活性和耐药性特征

Teresa I Ng, Preethi Krishnan, Tami Pilot-Matias, Warren Kati, Gretja Schnell, Jill Beyer, Thomas Reisch, Liangjun Lu, Tatyana Dekhtyar, Michelle Irvin, Rakesh Tripathi, Clarence Maring, John T Randolph, Rolf Wagner, Christine Collins

In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A

丙型肝炎病毒 NS5A 抑制剂奥比他韦的体外和体内抗病毒活性及耐药性特征

Preethi Krishnan, Jill Beyer, Neeta Mistry, Gennadiy Koev, Thomas Reisch, David DeGoey, Warren Kati, Andrew Campbell, Laura Williams, Wangang Xie, Carolyn Setze, Akhteruzzaman Molla, Christine Collins, Tami Pilot-Matias